Immunome Inc (IMNM) Stock Price, Quote & News

Company Profile

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug...

Industry: Biotechnology

Sector: Healthcare

Phone: 425 939 7410

Website: immunome.com

Address:

18702 North Creek Parkway, Suite 100, Bothell, United States

InvestorWisdom Nov. 14 at 4:28 PM

$IMNM This one could be ready to push out of a 4 week base and start a new uptrend

0 · Reply

RadioIsotope25 Nov. 12 at 11:19 PM

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 $IMNM $RADX $MNPR https://finance.yahoo.com/news/radiopharm-theranostics-starts-enrollment-third-133000810.html

0 · Reply

HunterT Nov. 11 at 8:48 PM

$IMNM nice march upwards into data!

0 · Reply

RadioIsotope25 Nov. 8 at 10:40 PM

$IMNM Would be a good acquisition for IMNM

0 · Reply

GSP Nov. 3 at 9:41 PM

$SPY $CSAI $GTLB $DXYZ $IMNM

1 · Reply

RadioIsotope25 Nov. 3 at 4:44 PM

$CATX $IOVA $IMNM

0 · Reply

HunterT Oct. 27 at 4:27 PM

$IMNM next leg up please! $20’s

0 · Reply

oldpoorboy Oct. 20 at 1:17 PM

$IMNM Someone buying my 3800 shares via covered calls.

0 · Reply

Jeff9905 Oct. 17 at 11:26 PM

$IMNM consolidation before next run up. Need data!!!?

0 · Reply

Cryptojoe9 Oct. 16 at 8:01 PM

$IMNM $21 soon

0 · Reply

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Infinimmune Announces Research Collaboration with Immunome

Sep 18, 2025, 8:00 AM EDT - 2 months ago

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Immunome Can Take The Fight To Competitors With Varegacestat

Jan 30, 2025, 10:27 AM EST - 10 months ago

Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium

Oct 8, 2024, 8:05 AM EDT - 1 year ago

Immunome Appoints Roee Shahar as Executive Vice President, Commercial

Sep 13, 2024, 7:00 AM EDT - 1 year ago

Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024

Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 29, 2024, 8:00 AM EDT - 1 year ago

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting

Immunome: An Oncology Powerhouse In The Making

Apr 2, 2024, 2:07 PM EDT - 1 year ago

Immunome Recognizes Ayala Pharmaceuticals' Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors

Immunome Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Feb 16, 2024, 4:05 PM EST - 1 year ago

0 · Reply

RadioIsotope25 Nov. 12 at 11:19 PM

0 · Reply

HunterT Nov. 11 at 8:48 PM

$IMNM nice march upwards into data!

0 · Reply

RadioIsotope25 Nov. 8 at 10:40 PM

$IMNM Would be a good acquisition for IMNM

0 · Reply

GSP Nov. 3 at 9:41 PM

$SPY $CSAI $GTLB $DXYZ $IMNM

1 · Reply

RadioIsotope25 Nov. 3 at 4:44 PM

$CATX $IOVA $IMNM

0 · Reply

HunterT Oct. 27 at 4:27 PM

$IMNM next leg up please! $20’s

0 · Reply

oldpoorboy Oct. 20 at 1:17 PM

$IMNM Someone buying my 3800 shares via covered calls.

0 · Reply

Jeff9905 Oct. 17 at 11:26 PM

$IMNM consolidation before next run up. Need data!!!?

0 · Reply

Cryptojoe9 Oct. 16 at 8:01 PM

$IMNM $21 soon

0 · Reply

Cryptojoe9 Oct. 16 at 8:00 PM

$IMNM adding here

0 · Reply

Tommyj1014 Oct. 16 at 4:08 PM

$IMNM my target was $16 from $9.

0 · Reply

HunterT Oct. 16 at 2:00 PM

$IMNM headed to $27 Alll aboard!!!!

0 · Reply

Ozzmosis Oct. 16 at 2:17 AM

$IMNM Relatively low interest in here in this one. It has been popping off quite a bit lately and has a high short interest. A squeeze could be huge as there is a high number of days to cover.

1 · Reply

RunnerSignals Oct. 15 at 8:46 PM

market warriors never quit $IMNM $DAWN $QNRX $ALEC $PHAT started red, ended green

1 · Reply

JasonBudd06 Oct. 15 at 8:16 PM

$IMNM something's up. Looking great.

0 · Reply

Tommyj1014 Oct. 15 at 7:59 PM

$IMNM News has to be close.

1 · Reply

dbr_island Oct. 15 at 7:47 PM

$SLNH read what I said below👇🏆 CIIT is my next load I’m telling you 🚨🚨🚨 $IMNM $RMSG $PFAI $MIGI what a day

0 · Reply

Elliotwavedave Oct. 15 at 7:23 PM

$IMNM xbi rockets

0 · Reply

Johnuser541 Oct. 15 at 6:35 PM

$IMNM where is this going?

1 · Reply

Tommyj1014 Oct. 15 at 5:57 PM

$IMNM creeping up 👀👀👀

0 · Reply

HunterT Oct. 14 at 6:20 PM

$IMNM holding the $14 mark here… interesting! 🫡

0 · Reply

Market Cap	1.60B
Revenue (ttm)	9.04M
Net Income (ttm)	-292.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,240.71%
Debt to Equity Ratio	0.00

Volume	1,914,000
Avg Vol	1,587,162
Day's Range	N/A - N/A
Shares Out	91.71M
Stochastic %K	85%
Beta	1.96
Analysts	Strong Sell
Price Target	$24.09